NCT03220373View on ClinicalTrials.gov

Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 7, 2017

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Substance Use Disorder (SUD)
Trial Locations (1)

0320

Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT03220373 - Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients | Biotech Hunter | Biotech Hunter